Literature DB >> 7460983

The clinical value of plasma and urinary carcinoembryonic antigen (CEA) assays in patients with haematuria and urothelial carcinoma.

R W Glashan, E Higgins, A M Neville.   

Abstract

A prospective clinical evaluation of plasma and urine carcinoembryonic antigen (CEA) in haematuria and urothelial carcinoma is presented. This study, in 325 patients, has shown that plasma CEA is of no value in the differential diagnosis of haematuria, T1 tumours or in the assessment of advanced bladder tumours with metastatic disease. Urinary CEA can be raised in the presence of urothelial carcinoma but is not a reliable diagnostic or prognostic index.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7460983     DOI: 10.1159/000473369

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  2 in total

1.  A new tumour marker tested in 98 patients with bladder carcinoma.

Authors:  S M Metcalfe; N V Jamieson
Journal:  Ann R Coll Surg Engl       Date:  1984-11       Impact factor: 1.891

Review 2.  Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?

Authors:  Nada Humayun-Zakaria; Douglas G Ward; Roland Arnold; Richard T Bryan
Journal:  Transl Androl Urol       Date:  2021-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.